17-63941939-C-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000334.4(SCN4A):c.4343G>C(p.Arg1448Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1448C) has been classified as Pathogenic.
Frequency
Consequence
NM_000334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hyperkalemic periodic paralysis Pathogenic:1Other:1
- -
This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 1448 of the SCN4A protein (p.Arg1448Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. This variant has been observed in an individual affected with paramyotonia congenita (PMID: 7676326, 8619545). ClinVar contains an entry for this variant (Variation ID: 221263). Experimental studies have shown that this missense change slows inactivation of the SCN4A channel and increases the amplitude of resurgent sodium currents (PMID: 8619545, 20038812, 21317558). Variants that disrupt the p.Arg1448 amino acid residue in SCN4A have been observed in affected individuals (PMID: 1316765, 7809121, 8005599, 8110459, 16801039, 18337730). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The R1448P variant in the SCN4A gene has been reported previously in association with cold-sensitive myotonia and weakness (Wang et al., 1995). This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R1448P variant is a non-conservative amino acid substitution, which occurs in the helical transmembrane segment S4 of repeat IV at a position that is conserved across species. Functional studies demonstrate that this variant slows inactivation of the sodium channel and increases the amplitude of resurgent sodium currents (Jarecki et al., 2010). Several missense variants at this amino acid position (R1448S, R1448C, R1448H, R1448L) have been reported in the Human Gene Mutation Database in association with paramyotonia congenita (Stenson et al., 2014), supporting the functional importance of this residue of the protein. We interpret R1448P as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at